Nova Leap Health Corp. (NLH.V)
TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
At close: 03:58PM EDT
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 41.23M |
| Enterprise Value | 47.06M |
| Trailing P/E | 19.94 |
| Forward P/E | 20.16 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.46 |
| Price/Book (mrq) | 1.71 |
| Enterprise Value/Revenue | 2.21 |
| Enterprise Value/EBITDA | 12.60 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.54 |
| 52-Week Change 3 | -41.67% |
| S&P500 52-Week Change 3 | -3.35% |
| 52 Week High 3 | 0.9900 |
| 52 Week Low 3 | 0.4450 |
| 50-Day Moving Average 3 | 0.5711 |
| 200-Day Moving Average 3 | 0.6274 |
Share Statistics
| Avg Vol (3 month) 3 | 38.31k |
| Avg Vol (10 day) 3 | 52.54k |
| Shares Outstanding 5 | 79.29M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 51.39M |
| % Held by Insiders 1 | 33.20% |
| % Held by Institutions 1 | 0.00% |
| Shares Short (Apr 28, 2022) 4 | 787 |
| Short Ratio (Apr 28, 2022) 4 | 0.02 |
| Short % of Float (Apr 28, 2022) 4 | N/A |
| Short % of Shares Outstanding (Apr 28, 2022) 4 | 0.00% |
| Shares Short (prior month Mar 30, 2022) 4 | 1.52k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Dec 30, 2021 |
Profitability
| Profit Margin | 8.27% |
| Operating Margin (ttm) | -5.79% |
Management Effectiveness
| Return on Assets (ttm) | -3.47% |
| Return on Equity (ttm) | 12.43% |
Income Statement
| Revenue (ttm) | 21.28M |
| Revenue Per Share (ttm) | 0.29 |
| Quarterly Revenue Growth (yoy) | 31.80% |
| Gross Profit (ttm) | 7.21M |
| EBITDA | -564.01k |
| Net Income Avi to Common (ttm) | 1.76M |
| Diluted EPS (ttm) | 0.0260 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.73M |
| Total Cash Per Share (mrq) | 0.02 |
| Total Debt (mrq) | 6.2M |
| Total Debt/Equity (mrq) | 33.55 |
| Current Ratio (mrq) | 0.96 |
| Book Value Per Share (mrq) | 0.23 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.18M |
| Levered Free Cash Flow (ttm) | -1.8M |
